Eledon Pharmaceuticals, Inc. Cash and Restricted Cash
Eledon Pharmaceuticals, Inc. (ELDN) had Cash and Restricted Cash of $6.80 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.80M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.15M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22.81M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.67M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $6.80M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $6.15M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $22.81M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $3.67M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $5.74M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $8.50M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $20.55M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $6.75M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $26.04M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $5.66M 10-Q/A · filed 2025-08-14 | |
| 2023-12-31 | $4.61M 10-K · filed 2026-03-19 | |
| 2023-09-30 | $3.67M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $40.95M 10-Q · filed 2024-08-19 | |
| 2023-03-31 | $46.48M 10-Q/A · filed 2024-08-19 | |
| 2022-12-31 | $56.41M 10-K/A · filed 2025-08-14 | |
| 2022-09-30 | $65.89M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $70.46M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $76.68M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $84.83M 10-K/A · filed 2024-08-19 | |
| 2021-09-30 | $94.04M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $101.13M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $108.58M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $114.19M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $114.46M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $8.76M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $11.79M 10-Q · filed 2021-05-14 | |
| 2019-12-31 | $8.79M 10-K · filed 2022-03-24 | |
| 2019-09-30 | $10.81M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $13.70M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $13.70M 10-Q · filed 2020-08-14 | $9.06M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $12.97M 10-K · filed 2021-03-31 | |
| 2018-09-30 | $16.32M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $19.19M 10-Q · filed 2019-08-13 | |
| 2018-03-31 | $22.52M 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $17.30M 10-K · filed 2020-03-17 | |
| 2017-09-30 | $19.16M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $22.58M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $635.00K 10-Q · filed 2018-05-11 | |
| 2016-12-31 | $1.12M 10-K · filed 2019-03-28 | |
| 2016-09-30 | $2.37M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $937.00K 10-Q · filed 2017-08-09 | |
| 2015-12-31 | $3.11M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |